| 摘要 |
This disclosure describes pharmaceutical compositions and a method for treatment of joint inflammation and pain brought about by e.g. arthritis, physical trauma, bacterial or viral infection. In one embodiment, the method comprises administration of a bimodal molecular weight dextran formulation comprising 0.2 to 32 % w/v of a dextran fraction with average molecular weight between 30,000 and 110,000 daltons and 0.2 to 6 % dextran with an average molecular weight between 500 and 3,000 daltons, into the joint of a warm blooded animal.
|
